Publication | Closed Access

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

ThrombopoiesisThrombosisPlatelet Aggregation InhibitorsCardiovascular DiseaseBlood PlateletPlatelet AggregationPharmacologyCardiovascular PharmacologyPharmacotherapyPublic HealthPlatelet AntagonistMedicineAnticoagulantCardiologyAcute Coronary Syndromes